The sticky issue of neurosteroids and GABA(A) receptors.
Endogenous neurosteroids and their synthetic analogs (neuroactive steroids) are potent modulators of GABA(A) receptors. Thus, they are of physiological and clinical relevance for their ability to modulate inhibitory function in the CNS. Despite their importance, fundamental issues of neurosteroid actions remain unresolved. Recent evidence suggests that glutamatergic principal neurons, rather than glia, are the major sources of neurosteroid synthesis. Other recent studies have identified putative neurosteroid binding sites on GABA(A) receptors. In this Opinion, we argue that neurosteroids require a membranous route of access to transmembrane-domain binding sites within GABA(A) receptors. This has implications for the design of future neuroactive steroids because the lipid solubility and related accessibility properties of the ligand are likely to be key determinants of receptor modulation.
Chisari
Mariangela
M
Department of Psychiatry, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO 63110, USA.
Eisenman
Lawrence N
LN
Covey
Douglas F
DF
Mennerick
Steven
S
Zorumski
Charles F
CF
D000818:Animals; D001665:Binding Sites; D002462:Cell Membrane / Q000737:chemistry / Q000378:metabolism; D002490:Central Nervous System / Q000166:cytology / Q000502:physiology; D008958:Models, Molecular; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011487:Protein Conformation; D011963:Receptors, GABA-A / Q000737:chemistry / Q000378:metabolism*; D009435:Synaptic Transmission / Q000502:physiology
D018377:Neurotransmitter Agents; D011963:Receptors, GABA-A
Nat Neurosci. 1999 Mar;2(3):219-25
10195213
Pharmacol Biochem Behav. 2005 Dec;82(4):712-20
16388839
J Membr Biol. 2004 Nov;202(2):61-72
15702370
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8198-203
15150412
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15218-23
14625373
Prostaglandins Other Lipid Mediat. 2005 Sep;77(1-4):210-8
16099405
Br J Pharmacol. 2008 Mar;153(5):1062-71
18204487
Br J Pharmacol. 2007 Jan;150(2):164-75
17160009
Neuropharmacology. 1996;35(9-10):1161-8
9014131
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13512-7
10557352
J Neurosci. 2004 Jul 28;24(30):6667-75
15282269
Recent Prog Horm Res. 1997;52:1-32
9238846
Neuroscience. 2006;138(3):749-56
16338086
Channels (Austin). 2007 Jul-Aug;1(4):238-45
18708751
Synapse. 1998 Jun;29(2):162-71
9593106
Pharmacol Ther. 2007 Oct;116(1):7-19
17560657
FEBS Lett. 2003 Nov 27;555(1):91-5
14630325
Br J Pharmacol. 1998 Nov;125(5):924-47
9846630
Endocrinology. 1999 Aug;140(8):3843-52
10433246
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14602-7
16984997
Neuroscience. 2006;138(3):821-9
16310966
J Neurosci. 2005 Dec 14;25(50):11605-13
16354918
J Neurosci. 2000 Mar 1;20(5):1982-9
10684899
Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S84-90
19632051
Mol Pharmacol. 2009 Jun;75(6):1400-11
19289569
Br J Pharmacol. 2009 Aug;157(8):1301-17
19594762
Nat Rev Neurosci. 2005 Jul;6(7):565-75
15959466
J Neurophysiol. 2009 Aug;102(2):1254-64
19553485
Eur J Neurosci. 2007 Oct;26(7):1881-8
17883414
Nature. 2004 Jul 8;430(6996):235-40
15241420
Curr Top Med Chem. 2002 Aug;2(8):795-816
12171572
Mol Pharmacol. 1993 May;43(5):813-9
7684817
Endocrinology. 2001 Aug;142(8):3578-89
11459806
J Steroid Biochem. 1975 May;6(5):607-13
1186246
Pharmacol Biochem Behav. 2006 Aug;84(4):581-97
16945406
Neuropharmacology. 2009 Jan;56(1):149-54
18762201
Biochemistry. 2009 Jul 28;48(29):6909-20
19552401
J Neurosci. 2002 Dec 15;22(24):10613-20
12486153
Nature. 2004 Jul 8;430(6996):232-5
15241419
J Neuroendocrinol. 2007 Apr;19(4):272-84
17355317
Neurosci Lett. 2005 Mar 29;377(2):130-5
15740851
Mol Pharmacol. 2009 Apr;75(4):973-81
19176850
Anesthesiology. 1997 Apr;86(4):903-17
9105235
Nat Neurosci. 2002 Aug;5(8):721-2
12118257
Brain Res. 1993 Dec 3;629(2):283-92
8111631
J Pharmacol Exp Ther. 2006 Mar;316(3):1360-8
16272217
Biochim Biophys Acta. 2007 Jan;1768(1):131-45
16945324
Steroids. 2009 Jul;74(7):577-85
19103212
Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S169-77
19577851
J Neurosci. 2009 Mar 11;29(10):3083-92
19279245
J Biol Chem. 2009 May 1;284(18):11771-5
19282280
Nature. 2006 Nov 23;444(7118):486-9
17108970
J Physiol. 2004 Jul 1;558(Pt 1):59-74
15146041
Neurochem Int. 2008 Mar-Apr;52(4-5):522-40
18068870
Biochemistry. 2008 Oct 21;47(42):11013-23
18821775
Pharmacol Ther. 2007 Oct;116(1):20-34
17531325
J Neurosci. 2006 Nov 8;26(45):11599-605
17093081
Mol Pharmacol. 2007 Jun;71(6):1582-90
17341652
J Neurosci. 2004 Jul 21;24(29):6521-30
15269263
Mol Pharmacol. 2006 Jun;69(6):1779-82
16527905
J Neurosci. 2003 Nov 26;23(34):10934-43
14645489
Neuropharmacology. 1998 Sep;37(9):1103-10
9833640
Eur Neuropsychopharmacol. 2008 Jan;18(1):24-33
17561380
Trends Pharmacol Sci. 2006 Mar;27(3):149-57
16483674
J Physiol. 2007 Nov 1;584(Pt 3):789-800
17761771
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2849-54
11226329
Br J Pharmacol. 2008 Feb;153(3):598-608
18037909
Trends Neurosci. 2009 Dec;32(12):629-37
19781792
Toxicol Lett. 1998 Nov 23;100-101:451-8
10049179
Pharmacol Ther. 2007 Oct;116(1):140-71
17555824
Mol Pharmacol. 1996 Dec;50(6):1581-6
8967980